×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Sensei Biotherapeutics Unveils Updated Corporate Presentation - TipRanks.com
Tipranks
An update from Sensei Biotherapeutics (SNSE) is now available. Sensei Biotherapeutics, Inc. has refreshed its corporate presentation, revealing it to the...
12 hours ago
Sensei Biotherapeutics to Participate in Jefferies Global Healthcare Conference
GlobeNewswire
BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on...
4 days ago
Sensei Biotherapeutics to Present New Preclinical Data at Upcoming Scientific Conferences
Yahoo Finance
BOSTON, March 06, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on...
2 months ago
Sensei Bio reports progress in cancer treatment trial By Investing.com
Investing.com
BOSTON - Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), an immuno-oncology company, announced positive preliminary data from the dose...
1 week ago
Rockville cancer therapy firm Sensei Biotherapeutics faces delisting threat from Nasdaq - Washington Business Journal
The Business Journals
The company, which went public in 2021, laid off a chunk of its workforce less than a year ago.
7 months ago
Why Is Sensei Biotherapeutics (SNSE) Stock Down 40% Today?
InvestorPlace
Sensei Biotherapeutics stock is falling on Friday as SNSE investors are unimpressed by its latest clinical trial data.
1 week ago
Sensei Biotherapeutics, Inc. (SNSE) Upgraded to Buy: Here's Why
Yahoo Lifestyle Canada
Sensei Biotherapeutics, Inc. (SNSE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings...
1 week ago
Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ...
GlobeNewswire
BOSTON, April 24, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on...
1 month ago
Is Sensei Biotherapeutics (NASDAQ:SNSE) In A Good Position To Deliver On Growth Plans?
Simply Wall Street
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
7 months ago
Sensei Biotherapeutics CFO Erin Colgan to resign By Investing.com
Investing.com
On Monday, Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), a biopharmaceutical company, announced the upcoming resignation of Erin Colgan,...
2 months ago